Save your place

Sign in to WhoBought

Please try again later.

CONMED Corporation (CNMD) institutional ownership

Latest close $43.45 Jul 20, 2026
Market cap$1.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
251
reported CNMD position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
125 buyers · 126 sellers

CONMED Corporation (CNMD) price and institutional activity

Dates

Q1 2026

$0 bought by 125 investors
Two Sigma Investments, LPBank of America Corp +123 more
$0 sold by 126 investors
Wasatch Advisors LPCitadel Advisors LLC +124 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

CONMED Corporation (CNMD) institutional activity · 251

Investor Type Est. change Change Δ Own Date
Wasatch Advisors LP · Exited
Change −575K Δ Own −100.0% Date Q1 2026
Wasatch Advisors LP Exited· Q1 2026 −575K −100.0% Q1 2026
Two Sigma Investments, LP · Added
Change +511K Δ Own +187.9% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +511K +187.9% Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −394K −61.5% Q1 2026
Bank of America Corp · Added
Change +336K Date Q1 2026
Bank of America Corp Added· Q1 2026 +336K Q1 2026
Hotchkis & Wiley Capital Management LLC · New
Change +317K Date Q1 2026
Hotchkis & Wiley Capital Management LLC New· Q1 2026 +317K Q1 2026
Ameriprise Financial Inc · Added
Change +294K Date Q1 2026
Ameriprise Financial Inc Added· Q1 2026 +294K Q1 2026
Arrowstreet Capital, Limited Partnership · Added
Change +287K Date Q1 2026
Arrowstreet Capital, Limited Partnership Added· Q1 2026 +287K Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main · Added
Change +284K Date Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main Added· Q1 2026 +284K Q1 2026
Silvercrest Asset Management Group LLC · Reduced
Change −218K Date Q1 2026
Silvercrest Asset Management Group LLC Reduced· Q1 2026 −218K Q1 2026
Invenomic Capital Management LP · Added
Change +197K Date Q1 2026
Invenomic Capital Management LP Added· Q1 2026 +197K Q1 2026
Jane Street Group, LLC · Reduced
Change −180K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −180K Q1 2026
Allspring Global Investments Holdings, LLC · Added
Change +166K Date Q1 2026
Allspring Global Investments Holdings, LLC Added· Q1 2026 +166K Q1 2026
Morgan Stanley · Reduced
Change −163K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −163K Q1 2026
Jones Financial Companies Lllp · Added
Change +161K Date Q1 2026
Jones Financial Companies Lllp Added· Q1 2026 +161K Q1 2026
Pacer Advisors, Inc. · Exited
Change −143K Δ Own −100.0% Date Q1 2026
Pacer Advisors, Inc. Exited· Q1 2026 −143K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 251

Famous investor activity in CONMED Corporation (CNMD)

CONMED Corporation (CNMD) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Gallagher John E. · Officer 3 operations 92K
Owned 31K Trade date Jul 15, 2026 Filed date Jul 17, 2026
Gallagher John E. Officer 3 operations 92K 31K Jul 15, 2026 Jul 17, 2026
Martin Celine Christine · Director Grant (A) 6K
Owned 6K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Martin Celine Christine Director Grant (A) 6K 6K Jul 1, 2026 Jul 2, 2026
Mirviss Jeffrey B. · Director Grant (A) 6K
Owned 6K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Mirviss Jeffrey B. Director Grant (A) 6K 6K Jul 1, 2026 Jul 2, 2026
Bronson David M. · Director 2 operations 0
Owned 0 Trade date Jun 2, 2026 Filed date Jun 3, 2026
Bronson David M. Director 2 operations 0 0 Jun 2, 2026 Jun 3, 2026
Council Laverne H. · Director 2 operations 0
Owned 0 Trade date Jun 2, 2026 Filed date Jun 3, 2026
Council Laverne H. Director 2 operations 0 0 Jun 2, 2026 Jun 3, 2026
Farkas Charles · Director 2 operations 0
Owned 0 Trade date Jun 2, 2026 Filed date Jun 3, 2026
Farkas Charles Director 2 operations 0 0 Jun 2, 2026 Jun 3, 2026
Kaye Mark · Director 2 operations 0
Owned 0 Trade date Jun 2, 2026 Filed date Jun 3, 2026
Kaye Mark Director 2 operations 0 0 Jun 2, 2026 Jun 3, 2026
Schwarzentraub Barbara J. · Director 2 operations 0
Owned 0 Trade date Jun 2, 2026 Filed date Jun 3, 2026
Schwarzentraub Barbara J. Director 2 operations 0 0 Jun 2, 2026 Jun 3, 2026
Bronson David M. · Director Grant (A) 6K
Owned 6K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Bronson David M. Director Grant (A) 6K 6K Jun 1, 2026 Jun 3, 2026
Council Laverne H. · Director Grant (A) 6K
Owned 6K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Council Laverne H. Director Grant (A) 6K 6K Jun 1, 2026 Jun 3, 2026
Kelderman Kim · Director Grant (A) 6K
Owned 6K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Kelderman Kim Director Grant (A) 6K 6K Jun 1, 2026 Jun 3, 2026
Farkas Charles · Director Grant (A) 6K
Owned 6K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Farkas Charles Director Grant (A) 6K 6K Jun 1, 2026 Jun 3, 2026
Kaye Mark · Director Grant (A) 6K
Owned 6K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Kaye Mark Director Grant (A) 6K 6K Jun 1, 2026 Jun 3, 2026
Schwarzentraub Barbara J. · Director Grant (A) 6K
Owned 6K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Schwarzentraub Barbara J. Director Grant (A) 6K 6K Jun 1, 2026 Jun 3, 2026
Beyer Pat · Officer Grant (A) 28K
Owned 28K Trade date Apr 1, 2026 Filed date Apr 2, 2026
Beyer Pat Officer Grant (A) 28K 28K Apr 1, 2026 Apr 2, 2026
15 of 38
15 of 38 Sign in to continue to older insider transactions.

CONMED Corporation (CNMD) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 5.0M
% of shares outstanding 16.4% Filing date Jan 22, 2024
BlackRock Inc. 5.0M 16.4% Jan 22, 2024
Vanguard Group Inc 3.4M
% of shares outstanding 11.1% Filing date Feb 13, 2024
Vanguard Group Inc 3.4M 11.1% Feb 13, 2024
Earnest Partners LLC 2.8M
% of shares outstanding 9.0% Filing date Nov 13, 2024
Earnest Partners LLC 2.8M 9.0% Nov 13, 2024
Vanguard Portfolio Management LLC 2.1M
% of shares outstanding 6.9% Filing date Apr 29, 2026
Vanguard Portfolio Management LLC 2.1M 6.9% Apr 29, 2026
Vanguard Capital Management LLC 1.6M
% of shares outstanding 5.2% Filing date Apr 29, 2026
Vanguard Capital Management LLC 1.6M 5.2% Apr 29, 2026
Capital Research Global Investors 1.5M
% of shares outstanding 5.0% Filing date Nov 12, 2024
Capital Research Global Investors 1.5M 5.0% Nov 12, 2024
Champlain Investment Partners, LLC 1.3M
% of shares outstanding 4.2% Filing date Feb 13, 2023
Champlain Investment Partners, LLC 1.3M 4.2% Feb 13, 2023
7 of 7

CONMED Corporation (CNMD) ownership FAQ

Who owns CNMD?

251 reporting institutions disclosed CNMD position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.